AU495840B2 - - Google Patents

Info

Publication number
AU495840B2
AU495840B2 AU65910/74A AU6591074A AU495840B2 AU 495840 B2 AU495840 B2 AU 495840B2 AU 65910/74 A AU65910/74 A AU 65910/74A AU 6591074 A AU6591074 A AU 6591074A AU 495840 B2 AU495840 B2 AU 495840B2
Authority
AU
Australia
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU65910/74A
Other languages
English (en)
Other versions
AU6591074A (en
Publication of AU495840B2 publication Critical patent/AU495840B2/en
Priority claimed from GB914973A external-priority patent/GB1476422A/en
Application filed filed Critical
Publication of AU6591074A publication Critical patent/AU6591074A/en
Expired legal-status Critical Current

Links

AU65910/74A 1973-02-23 1974-02-22 Glycoprotein from bacteria Expired AU6591074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB914973A GB1476422A (en) 1973-02-23 1973-02-23 Biological extracts

Publications (2)

Publication Number Publication Date
AU495840B2 true AU495840B2 (https=)
AU6591074A AU6591074A (en) 1975-08-28

Family

ID=9866339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65910/74A Expired AU6591074A (en) 1973-02-23 1974-02-22 Glycoprotein from bacteria

Country Status (12)

Country Link
JP (1) JPS5063196A (https=)
AU (1) AU6591074A (https=)
BE (1) BE811491A (https=)
DE (1) DE2408724A1 (https=)
DK (1) DK141757B (https=)
FR (1) FR2218888B1 (https=)
GB (1) GB1476422A (https=)
HU (1) HU173676B (https=)
IE (1) IE39332B1 (https=)
IL (1) IL44267A (https=)
NL (1) NL7402455A (https=)
ZA (1) ZA741189B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2410476B1 (fr) * 1977-11-30 1980-08-22 Inst Nat Sante Rech Med Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白wenac及びその製造法
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
FR2480604A1 (fr) * 1980-04-22 1981-10-23 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation
US4871488A (en) * 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
LT3049430T (lt) * 2014-07-16 2019-04-10 Depofarma S.P.A. Propionibacterium granulosum parietalinė frakcija, atliekanti imunomoduliacinius veiksmus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450815A (en) * 1964-04-24 1969-06-17 Princeton Lab Inc Method of stimulating a host defense mechanism with an actinovaccine
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections

Similar Documents

Publication Publication Date Title
US10576109B2 (en) Propionibacterium acnes and granulosum parietal fraction having immunomodulating action
EP0024941B1 (en) Water-soluble extract from nonpathogenic aerobic corynebacteria, production thereof and compositions containing the extract
AU495840B2 (https=)
FR2218888B1 (https=)
FR2410476B1 (fr) Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale
FR2502496B2 (https=)